Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

Crispr Therapeutics (CRSP) has disclosed a new risk, in the Innovation / R&D category. Crispr Therapeutics faces a significant business risk due ...

Biohacking has moved from niche experiments to a global movement reshaping how we think about human potential. With ...

T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

ARK Innovation portfolio metrics are strong, and the vehicle likely presents diversification benefits. Click here to read an ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

The genome of the yeast Saccharomyces Cerevisiae was finally synthesized and for the first time ever scientists have created ...

Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...

"The study's results provide insights into some known and previously unrecognised benefits and risks of GLP-1RA that may be useful to inform clinical care and guide research agendas. While ...

Imagine one morning, you are deciding whether to drive to work or catch the train. Eventually, you decide to drive. On your way to the office, a squirrel crosses the road leaving you no time to react, ...